glioblastoma | Stock Gumshoe

August 17, 2017 / Michael Jorrin, "Doc Gumshoe"

What’s New this Summer?

Doc Gumshoe checks in on CAR-T, HRT, Prostate Cancer and more...

Comments

mattremote on Stansberry Venture’s “Major Announcement” — What are the Three Companies facing a Wave of Money? / Oct 14, 10:26am

Hey allgood: It's "Novocure." Their product, I think it's called Optune in the U.S., looks like science-fiction but it...

mattremote on What’s the Stock Behind Chris Wood’s “Magical” Anti-aging pill? / Jul 28, 10:32pm

lalgulab12 makes an interesting point. Studies indicate NAD+ and NMN appear to correlate with an upward trend in the l...

Yelpik on

Discussion page for Arch Therapeutics (ARTH) / Jan 10, 9:39am

Medicenna is exciting for the fact that they seem to have a treatment glioblastoma. I lost a good friend to it years ago...

highdrat3r on Michael Robinson’s “ONLY Solution” for COVID-19 (with June 30 Results Expected!) / May 28, 7:44pm

Yes the covid-19 vaccine race is definitely a bubble similar to the latest weed bubble not too long ago. However, if I ...

Big Mahalo on Cancer Treatment 2018: Looking Towards the Future / Jan 20, 11:39am

In regards to Glioblastoma NWBO, deep in OTC penny land, is hopefully close to P3 results. Anecdotal comments suggest ...

admdr5 on The Twelve Biotechs of Christmas 2018: Balthasar / Jan 24, 7:37am

$DFFN UWCHARLOTTESVILLE, Va., Jan. 24, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq:DFFN) (Diffu...

SoGiAm on Dr. KSS Posts from Biotech Showcase 2018, San Francisco / Jan 9, 6:39am

$DFFN bid os - https://finviz.com/quote.ashx?t=DFFN #Diffusio2n http://www.diffusionpharma.com/scientific-advisory-boar...

admdr5 on Dispelling Certain Aurinia ($AUPH) Rumors / Dec 29, 9:35am

$DMPI LONG29-Dec-2017:08:43:00, DelMar Pharmaceuticals Announces Fast Track Designation for VAL-083 in Recurrent G...

admdr5 on Dispelling Certain Aurinia ($AUPH) Rumors / Dec 26, 10:00am

$DPMI26-Dec-2017:05:30:00, DelMar Pharmaceuticals Announces Fast Track Designation for VAL-083 in Recurrent Glioblas...

SoGiAm on Is a Misperception Subduing Share Price at Aptose ($APTO)? / Dec 18, 8:35am

$VBLT np - New Biomarker Data Supports Direct Link between VB-111’s Dual Mechanism of Action and its Clinical Effect o...

SoGiAm on Is a Misperception Subduing Share Price at Aptose ($APTO)? / Dec 11, 8:15pm

$MBRX 1/2p - Please be advised, the Moleculin Biotech, Inc. (Nasdaq: MBRX) management team including, Walter Klemp, CE...

SoGiAm on Tear Sheet: CohBar Inc. ($CWBR) / Nov 18, 11:42am

$TRIL - Society for Neuro-Oncology 22nd Annual Meeting poster: http://s2.q4cdn.com/772010778/files/doc_presentations/20...

admdr5 on “Notes from Torrey Hills Capital Emerging Growth Conference, 13-15 November 2017, San Diego, CA” / Nov 16, 7:11am

$STML LONGNEW YORK, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage b...

admdr5 on Tear Sheet: CohBar Inc. ($CWBR) / Nov 9, 4:26pm

$ STML LongMore News09-Nov-2017:16:01:00, Stemline Therapeutics Reports Third Quarter 2017 Financial Result...

SoGiAm on

BIotech/Medical Catalyst Calender / Oct 26, 8:34pm

$TRIL - November 18, 2017 05:00 PM PST San Francisco, CA Presenter: Zezhou Wang, Ph.D., Trillium Research Scientist h...

admdr5 on Tear Sheet: CohBar Inc. ($CWBR) / Oct 20, 7:03am

NP $ VBLT 07:01 VBLT Vascular Biogenics announces that the EMA has designated ofranergene obadenovec (VB-11...

admdr5 on Tear Sheet: CohBar Inc. ($CWBR) / Oct 11, 8:52am

NP $ MBRXheflyonthewall.com: Moleculin announces strategic collaboration to develop immune stimulation drug Molec...

Nick Franco on What’s New this Summer? / Aug 17, 11:12am

Michael, Why have you not discussed the phase 3 results of Northwest Bio on the most deadly form of glioblastoma?...

cw99 on Oncotutorial / Aug 11, 3:28pm

$ABIO and others Thx Levbrans. Re: ABIO. I have a morbidly obese position with avg price of 2.00, so I'm down about 30...

cw99 on Oncotutorial / Aug 3, 9:40am

$ABIO $BLPH $VBLTJust added heavily to all 3 positions and now OW.ABIO: Briefly, they are developing the Beta ...

savethemanatee on Long Idea of the Year / Jun 20, 1:11pm

$VBLT.Thanks, Doc. To be clear about this, I'm not questioning your medical knowledge or investment advice, both of...

mvssysprog on Friday File: Biotech Insider Alert hints at “128,756% Sales Growth on June 23” From “CD19 Vaccine” / Jun 20, 10:00am

vanderwall7, you said there has never been a cure of a glioblastoma multiforma tumor. I've been following a doctor in Ho...

schubrrw3212 on Friday File: Biotech Insider Alert hints at “128,756% Sales Growth on June 23” From “CD19 Vaccine” / Jun 17, 7:38pm

There has been a glioblastoma multiforma that was held in remission for 5 years, using a low-temperature water extract o...

vanderwall7 on Friday File: Biotech Insider Alert hints at “128,756% Sales Growth on June 23” From “CD19 Vaccine” / Jun 16, 2:05pm

One of the example he used was a GBM that went into remission. To my knowledge there has never been a cure of a GBM whi...

SoGiAm on

BIotech/Medical Catalyst Calender / Jun 14, 8:18am

$VBLT - 2 conference presentations: http://ir.vblrx.com/phoenix.zhtml?c=253311&p=irol-news&nyo=02017 BIO ...

admdr5 on Long Idea of the Year / Jun 5, 7:56am

$ VBLT. LongVBL Therapeutics announces VB-111 phase 2 data presented at ASCO VBL Therapeutics announced the present...

cw99 on Long Idea of the Year / May 17, 10:29am

$VBLTDoc, here is a transcript of their CC from 2 days ago. Still looking good IMO.Re: Their GBM, they expect in...

kucheka on The Conversation: ScyNexis ($SCYX) CFO Eric Francois / Apr 26, 10:40am

$CLRB longShares down on (despite?) patent news:Apr 25, 2017: Cellectar Biosciences Receives Additional U.S. Patent...

linling88 on Live Blog: Akari Therapeutics R & D Day, April 24, 2017 / Apr 25, 11:05am

$VBLTVBL Therapeutics Announces Upcoming Presentations on VB-111 at the ASCO and ASGCT 2017 Conferences -TEL AVI...

admdr5 on Quickster: Update on Corbus / Apr 20, 5:07pm

$ VBLT Long20-Apr-2017:16:01:00, VBL Therapeutics Announces Positive DSMC Review in Phase 3 GLOBE Trial Investigat...

SoGiAm on The Rest of the 12 Biotechs of Christmas / Feb 22, 7:52am

$AGEN np - Agenus’ lead cancer vaccine flops, investigators read last rites over glioblastoma PhII $AGEN -5.5% https:...

linling88 on The Rest of the 12 Biotechs of Christmas / Feb 21, 7:28am

$STML:Stemline Therapeutics Provides Update on Clinical ProgramsSL-401--Patient enrollment has continued to...

SoGiAm on Noblecon13 Live Blog / Feb 2, 7:51am

Revolutionary approach for treating glioblastoma works with human cells News Release: For immediate use: Revolutionary...

chris27 on The Twelve Biotechs of Christmas: One / Jan 29, 4:01pm

Hi everyone, According to the trusted source: @AndyBiotech $TCON will soon release their TRC105 & Avastin 1012 mont...

linling88 on The Twelve Biotechs of Christmas: One / Jan 6, 2:18pm

$VBLT:VBL Therapeutics Announces Completion of Enrollment in the Pivotal GLOBE StudyJanuary 6, 2017 TEL AVIV, I...

russwkennel on Responses to Recent Comments / Dec 28, 5:37pm

Berberine. Here is what I found at LEF.Com.Berberine is an alkaloid found in various different medicinal herbs. Prob...

DrKSSMDPhD on The Twelve Biotechs of Christmas: One / Dec 17, 8:20pm

DB: that was among my very first questions in picking through what I CAN access on NSI-189. Some of it is proprietary, B...

DBMD on The Twelve Biotechs of Christmas: One / Dec 17, 8:11pm

$CUR I was just looking at that stock and was a little bit concerned about the possibility of causing other neural tissu...

SoGiAm on Such A Pleasant Stay / Nov 21, 8:43am

$STML long - Stemline Therapeutics Announces Oral Presentation of SL-701 Phase 2 Data in Second-Line Glioblastoma at t...

linling88 on Sea of Tranquility / Oct 27, 9:56am

$AGEN:Agenus Reports Third Quarter Financial Results and Recent Highlights/Development Updates Company to host conf...

AC/DC on

Discussion re $ARTH / Oct 13, 5:50pm

From a quick read, their focus is totally different. These are the two treatments they are actively pursuing:1. Brai...

linling88 on Sea of Tranquility / Oct 11, 5:16pm

The most devastating aspect of $BMY's "epic failure" was that, in the trial for NSCLC as front-line therapy, Opdivo fail...

arch1 on Sea of Tranquility / Oct 11, 6:22am

ben Thank you . That makes eminent sense to me and is quite astounding that such a small sample may yield results. This ...

diplacus on Quickster: Introducing ScyNexis ($SCYX), a New Antimicrobial Play / Jun 19, 10:37am

$VBLT -- Dr. KSS: On June 10, you said "Biggest problem is that it can only be given once" (in context of glioblastoma...

DrKSSMDPhD on Quickster: Introducing ScyNexis ($SCYX), a New Antimicrobial Play / Jun 17, 2:57pm

$VBLT is VBL Technologies, formerly Vascular Biogenics, an Israeli firm. I took a position because I was impressed with ...

arch1 on Quickster: The Long Case for Ignyta ($RXDX) / May 31, 12:42pm

Dr KSS I don't know if you have seen this ,,,It seems to me this is worth noting on brain barrier crossing. The blood-b...

SoGiAm on The Bedlam in Young Goliath / May 18, 5:53pm

$KPTI nada - Karyopharm to Present Selinexor Clinical Data at the American Society of Clinical Oncology Annual Meeting ...

DrKSSMDPhD on The Bedlam in Young Goliath / May 16, 1:51pm

As to the discussion of Duke's modified poliovirus for glioblastoma multiforme, as best I can tell this study or its IP ...

Leslie on Barcelona Hot Type: Will GS-4997 Make $GILD Golden Again? / Apr 30, 9:04am

Make that three of us. I added to my modest position yesterday. Also loved the study Glenn shared about efforts to cross...

arch1 on Barcelona Hot Type: Will GS-4997 Make $GILD Golden Again? / Apr 28, 5:24am

glenn Thanks for this post. My youngest son died of glioblastoma in his late forties....

AC/DC on Special Commentary: Turbulence for Esperion / Mar 4, 8:07pm

$KPTIFrom Bens link, it does look promising for Selinexor. Unfortunately I opened my full position at the peak (~$30...

DBMD on Will February Bring a Swing Trade in Regulus ($RGLS)? / Feb 5, 5:33pm

Glioblastoma is a bad dz, usually not much after 6 months of dx people were dead. This has improved some. Gamma knife us...

SoGiAm on The Manchurian Candida / Dec 30, 7:27pm

AGEN, AKBA, PIRS, FLKS: Extracted from: http://www.thelifesciencesreport.com/pub/na/panelists-select-19-companies-for-t...

newby3867 on The Manchurian Candida / Nov 6, 1:38pm

Getting a gut feeling that AGEN is sitting on some great news coming with several strong catalysts coming into play. The...

SoGiAm on

Is Zafgen Kaput? / Oct 29, 4:29pm

Phase 2 Study of MEDI4736 in Patients With Glioblastoma https://clinicaltrials.gov/ct2/show/study/NCT02336165?term=MEDI...

SoGiAm on The Tao of Recro / Oct 9, 5:11pm

NVCR- FDA Approves Optune in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma http://...

DrKSSMDPhD on A Biotech Long Idea Brought to You on Bended Knee / Jun 6, 10:19am

I entered Agenus $AGEN this past week.Since we now have evidence of efficacy on multiple fronts---genital herpes, sh...

DrKSSMDPhD on A Biotech Long Idea Brought to You on Bended Knee / Jun 1, 2:00pm

OK, I will honorably concede a certain measure of defeat as regards $CLDX. Its immune-tweaking agent rindopepimut, combi...

frankw17 on Cisco, Chang & Charlie / May 27, 6:12pm

$KPTI: Karyopharm to Present Clinical Data Update for Selinexor (KPT-330) in Solid Tumors- Presentation to Include ...

Vijay on The Last Samurai Biotech / May 14, 11:28am

$KPTI. from leerink asco abstracts.• KPTI (OP): Ph II data for selinexor suggests single agent activity in solid...

newby3867 on The Last Samurai Biotech / May 13, 7:37pm

Karyopharm (KPTI) presenting solid tumor data on Selinxor at ASCO. Promising antitumor activity was observed in abstrac...

Frenchy on The Last Samurai Biotech / May 5, 3:37pm

$ZIOP: Ziopharm initiates Phase 1 gene therapy trial in brain cancer-Ziopharm Oncology (NASDAQ:ZIOP) commences a Ph...

danmcco on written by reader

Gumshoe BioDimSum II: Corralling the “A” Biotechs Plus a New Long Selection / Mar 19, 10:22am

Ok this does come from SA but it was very interesting nonetheless. It looks to be similar to Cellectis.http://seekin...

KennyG on

The Zed Files / Feb 23, 9:56am

$CLDX up 15% this morning based on this FDA granting rindopepimut (Rintega(R)) Breakthrough Therapy Designation for the ...

Steve L on written by reader

Cancer Care: Current Directions / Feb 21, 6:06am

Ok that "global stomp" in my last post should say glioblastoma!Damn auto correct!...

DrKSSMDPhD on written by reader

Saving Jack Kerouac / Feb 18, 4:41pm

Even with a CAR-T-entrained approach against the mutant EGF regions typifying glioblastoma multiforme, anti-tumor respon...

DrKSSMDPhD on written by reader

Saving Jack Kerouac / Feb 16, 10:51am

Hi edinle....$CLDX has come up several times in the threads, but to summarize:(1) I predict phase 3 failure for rind...

Leslie on

Saving Jack Kerouac / Feb 16, 10:32am

Doc, If you have time, could you give us an opinion about CLDX. The pipeline includes rindopepimut, in P3 trials for gl...

gggb on The 2015 Stock Gumshoe Biotechnology Awards Show! / Jan 19, 12:25pm

Northwest Biotherapeutic (NWBO) might deserve a mention in this list. NW Bio is Developing dendritic cell-based vaccines...

DrKSSMDPhD on written by reader

Dawn of the Planet of the TLOGlodytes! / Dec 10, 1:11pm

Glenn, I think you asked earlier about Northwest Biotherapeutics and its dendritic cell vaccine program for glioblastoma...

DBMD on “Rare Move by FDA to Ignite Tiny $4 Stock” with a “35-to-1 Bang” / Nov 21, 6:08am

Janus Associated Kinase 2 (JAK2) and FMS-like tyrosine kinase 3 (FLT3) for myleodysplasia, old blood. They have competit...

tyler123dogfiddle on written by reader

Payola from Portola? / Nov 16, 3:34pm

Hello Dr K, according to their website this method/device already has FDA approval for and is already in use for re-cur...

DrKSSMDPhD on written by reader

Payola from Portola? / Nov 15, 4:52pm

NEVER AGAIN IN THIS INCARNATION WILL YOU SEE THIS HAPPEN: a phase 3 trial for glioblastoma stopped early on unprecedent...

DrKSSMDPhD on written by reader

Ebola: To Parse, Perchance to Parlay / Nov 5, 2:52pm

Kenny:I don't mean to ruffle any feathers, but I am of little or no faith in $CLDX. Its glioblastoma program themed ...

AC/DC on

Hepatitis with a C: Right Now Someone You Know Has It (and Doesn’t Know) / May 29, 3:18am

I had no idea so many companies are working on so many drugs. Are all of them private companies except ISIS?ISIS: ...

robertvince on written by reader

Blood Purification companies discussion / Mar 19, 11:07am

Some great news from AEMD dealing with brain cancer:Aethlon Medical and Exosome Sciences Expand Brain Research Disco...

2sheps on A Biotech Trading Experiment … / Feb 25, 8:33pm

This is an interesting experiment, Travis. I have two specs that I am currently playing. One is Northwest Biotherapeut...

karmaswimswami on “This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug” / Feb 1, 1:26pm

Siva: I don't mean to sound like the Herb Greenberg of Gumshoe, but I just cannot see a case for IMUC at all. It issued ...

Robert V on written by reader

Stellar Biotechnologies – The real deal or just more tulip bulbs? / Nov 22, 10:02am

Found this Seeking Alpha article today about Celldex and its glioblastoma vaccine (which includes Stellar's KLH), could...

Will on

Stellar Biotechnologies – The real deal or just more tulip bulbs? / Oct 21, 12:47pm

Thanks for the reply AH. I used the lower range of numbers that Stellar estimated (in their investor presentation) as y...

Topic Archives: glioblastoma

Articles

What’s New this Summer?

Comments

Updating your Credit Card in PayPal